5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

C130H119F4N29O10 — CID 157161323

IUPAC5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESNc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4NC(=O)C4CC4)c3c2)c1.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)C4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(N4CCCC4)c3)cc12
InChIInChI=1S/C29H28F2N6O2.C28H26F2N6O2.C27H26N6O2.C23H20N6O2.C23H19N5O2/c30-29(31)9-11-37(12-10-29)17-18-13-21(16-32-15-18)20-7-8-23-22(14-20)26(36-35-23)28(39)34-25-4-2-1-3-24(25)33-27(38)19-5-6-19;29-28(30)9-10-36(16-28)15-17-11-20(14-31-13-17)19-7-8-22-21(12-19)25(35-34-22)27(38)33-24-4-2-1-3-23(24)32-26(37)18-5-6-18;34-26(17-7-8-17)29-23-5-1-2-6-24(23)30-27(35)25-21-14-18(9-10-22(21)31-32-25)19-13-20(16-28-15-19)33-11-3-4-12-33;24-16-9-15(11-25-12-16)14-7-8-18-17(10-14)21(29-28-18)23(31)27-20-4-2-1-3-19(20)26-22(30)13-5-6-13;29-22(14-7-8-14)25-19-5-1-2-6-20(19)26-23(30)21-17-12-15(9-10-18(17)27-28-21)16-4-3-11-24-13-16/h1-4,7-8,13-16,19H,5-6,9-12,17H2,(H,33,38)(H,34,39)(H,35,36);1-4,7-8,11-14,18H,5-6,9-10,15-16H2,(H,32,37)(H,33,38)(H,34,35);1-2,5-6,9-10,13-17H,3-4,7-8,11-12H2,(H,29,34)(H,30,35)(H,31,32);1-4,7-13H,5-6,24H2,(H,26,30)(H,27,31)(H,28,29);1-6,9-14H,7-8H2,(H,25,29)(H,26,30)(H,27,28)
InChIKeyAMKGUMQIRXIQRQ-UHFFFAOYSA-N
MW2323.57 g/mol
LogP23.38
Rot. Bonds30

About 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide

5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (PubChem CID 157161323) has the molecular formula C130H119F4N29O10 and a molecular weight of 2323.57 g/mol. Its IUPAC name is 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.

Molecular Properties

Compound Name5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
PubChem CID157161323
Molecular FormulaC130H119F4N29O10
Molecular Weight2323.57 g/mol
Exact Mass2321.96
IUPAC Name5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
SMILESNc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4NC(=O)C4CC4)c3c2)c1.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)C4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(N4CCCC4)c3)cc12
InChIInChI=1S/C29H28F2N6O2.C28H26F2N6O2.C27H26N6O2.C23H20N6O2.C23H19N5O2/c30-29(31)9-11-37(12-10-29)17-18-13-21(16-32-15-18)20-7-8-23-22(14-20)26(36-35-23)28(39)34-25-4-2-1-3-24(25)33-27(38)19-5-6-19;29-28(30)9-10-36(16-28)15-17-11-20(14-31-13-17)19-7-8-22-21(12-19)25(35-34-22)27(38)33-24-4-2-1-3-23(24)32-26(37)18-5-6-18;34-26(17-7-8-17)29-23-5-1-2-6-24(23)30-27(35)25-21-14-18(9-10-22(21)31-32-25)19-13-20(16-28-15-19)33-11-3-4-12-33;24-16-9-15(11-25-12-16)14-7-8-18-17(10-14)21(29-28-18)23(31)27-20-4-2-1-3-19(20)26-22(30)13-5-6-13;29-22(14-7-8-14)25-19-5-1-2-6-20(19)26-23(30)21-17-12-15(9-10-18(17)27-28-21)16-4-3-11-24-13-16/h1-4,7-8,13-16,19H,5-6,9-12,17H2,(H,33,38)(H,34,39)(H,35,36);1-4,7-8,11-14,18H,5-6,9-10,15-16H2,(H,32,37)(H,33,38)(H,34,35);1-2,5-6,9-10,13-17H,3-4,7-8,11-12H2,(H,29,34)(H,30,35)(H,31,32);1-4,7-13H,5-6,24H2,(H,26,30)(H,27,31)(H,28,29);1-6,9-14H,7-8H2,(H,25,29)(H,26,30)(H,27,28)
InChIKeyAMKGUMQIRXIQRQ-UHFFFAOYSA-N
XLogP23.38
TPSA534.59 Ų
H-Bond Donors16
H-Bond Acceptors24
Rotatable Bonds30
Heavy Atoms173
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002323.57
LogP ≤ 523.38
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1024

Analyze 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The IUPAC name of 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide (CID 157161323) is 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide.
What is the SMILES notation for 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The canonical SMILES for 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4NC(=O)C4CC4)c3c2)c1.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)C4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12.O=C(Nc1ccccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(N4CCCC4)c3)cc12.
What is the InChIKey of 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
The InChIKey is AMKGUMQIRXIQRQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H28F2N6O2.C28H26F2N6O2.C27H26N6O2.C23H20N6O2.C23H19N5O2/c30-29(31)9-11-37(12-10-29)17-18-13-21(16-32-15-18)20-7-8-23-22(14-20)26(36-35-23)28(39)34-25-4-2-1-3-24(25)33-27(38)19-5-6-19;29-28(30)9-10-36(16-28)15-17-11-20(14-31-13-17)19-7-8-22-21(12-19)25(35-34-22)27(38)33-24-4-2-1-3-23(24)32-26(37)18-5-6-18;34-26(17-7-8-17)29-23-5-1-2-6-24(23)30-27(35)25-21-14-18(9-10-22(21)31-32-25)19-13-20(16-28-15-19)33-11-3-4-12-33;24-16-9-15(11-25-12-16)14-7-8-18-17(10-14)21(29-28-18)23(31)27-20-4-2-1-3-19(20)26-22(30)13-5-6-13;29-22(14-7-8-14)25-19-5-1-2-6-20(19)26-23(30)21-17-12-15(9-10-18(17)27-28-21)16-4-3-11-24-13-16/h1-4,7-8,13-16,19H,5-6,9-12,17H2,(H,33,38)(H,34,39)(H,35,36);1-4,7-8,11-14,18H,5-6,9-10,15-16H2,(H,32,37)(H,33,38)(H,34,35);1-2,5-6,9-10,13-17H,3-4,7-8,11-12H2,(H,29,34)(H,30,35)(H,31,32);1-4,7-13H,5-6,24H2,(H,26,30)(H,27,31)(H,28,29);1-6,9-14H,7-8H2,(H,25,29)(H,26,30)(H,27,28).
What are the key properties of 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide?
5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide has a molecular weight of 2323.57 g/mol, XLogP of 23.38, 30 rotatable bonds, 16 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide is sourced from PubChem (CID 157161323), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).